
Carna Health and Renalytix™ announce partnership to bridge gap between population screening and precision intervention.
Read moreCarna is the AI-driven platform public and private healthcare systems deploy to detect, manage, and prevent Cardio-Kidney-Metabolic syndrome.
Healthcare Sector
Evaluated alongside Alphabet (#1), Microsoft (#2), Nvidia (#7), and OpenAI (#66) — out of 300 companies globally.
Overall Rank
All Companies Globally
Companies Ranked
90% of CKD patients are completely unaware of their condition. Without proactive screening programs and patient engagement tools, communities remain blind to a disease that has no symptoms until it's too late to prevent catastrophic outcomes.
Point-of-care testing infrastructure is absent in most primary care settings. Without scalable, affordable diagnostics and predictive analytics, health systems can't find disease early — especially in low-resource and rural communities.
CKM management requires coordinated care across primary care, nephrology, cardiology, and endocrinology — but most systems operate in silos. Without shared data and integrated pathways, patients fall through the gaps.
FDA-cleared POCT devices. eGFR & uACR in under 15 minutes — no lab or specialist required. Deployable in hospitals, clinics, pharmacies, or rural community centers.
Identifies which screened patients will likely progress to advanced CKD — before deterioration. Flags high-risk individuals and generates targeted referral pathways in real-time.
AI-guided workflows empower nurses, pharmacists, and primary care providers to manage complex CKM cases — without specialist referral. Closes the global specialist gap.
Universal data ingestion from POCT, labs, EHR, HIEs, wearables, and SDoH sources. Leveraging FHIR / HL7 / API for faster integration with client systems

Carna Health is at the forefront of chronic disease innovation, merging groundbreaking technology with a deep commitment to patient care.
Carna Health empowers health systems around the globe to expand their vision and understanding of what is possible with proactive disease identification and adoption of digital health as pillar in chronic disease care pathways.
Carna Health welcomes partnerships that expand and diversify our global footprint. Our impact partners also prioritize increasing healthcare access for everyone, promote gender equality and combat the effects of climate change on chronic disease.
Carna Health provides decision support resources while also upskilling resource-restrained healthcare environments. From the onset, providers are equipped with a integrated point-of-care disease identification technology, educational resources for patients, and care pathway automation tool.
Carna Health empowers patients with healthcare data, personalized educational resources and connectivity to their provider network. Through the Carna Patient App, patients can unlock benefits that have previously created access challenges.

Fast Company

PR Newswire

Yahoo Finance

BusinessWire

Salvatore G. Viscomi, MD
CEO & Co - Founder